OTC · Financial Statements

Comera Life Sciences Holdings, Inc. (CMRA) Financial Statements

$0.00 OTC: CMRA Market Cap $3074

Comera Life Sciences Holdings, Inc. most recently reported annual revenue of $1.0M, net profit of $-18.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric202020212022
Revenue$0$0$1.0M
Operating Profit$-2.0M$-6.0M$-12.0M
Net Profit$-2.0M$-5.0M$-18.0M
EPS$-0.11$-0.29$-1.76
Op Margin-480.3%-1730.8%-1890.7%

Balance Sheet (USD)

Metric202020212022
Total Assets$1.0M$7.0M$4.0M
Total Liabilities$0$22.0M$10.0M
Cash$0$7.0M$0
Borrowings$0$0$1.0M

Cash Flow (USD)

Metric202020212022
Operating Cash Flow$-2.0M$-4.0M$-10.0M
Investing Cash Flow$0$0$0
Financing Cash Flow$0$0$5.0M
Net Cash Flow$0$6.0M$-5.0M
Free Cash Flow$-2.0M$-4.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.02
FCF Yield-318815.13%
Quick Ratio0.61
Interest Coverage-587.02
Return 1Y-50.00%
Return 3Y-99.98%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
CMRA Overview CMRA Dividend Run Stock Screener